Accrued Expenses and Other Long-Term Liabilities (Tables)

9 Months Ended

Jun. 30, 2022

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities as well as Other Long-Term Liabilities

Accrued expenses and other current liabilities, as well as other long-term liabilities, consisted of the following as of June 30, 2022 and September 30, 2021:

	June 30,		September 30,
	2022		2021
	(in thousands)
Accrued expenses:
Accrued pharmaceutical drug manufacturing	$	7,614	$	8,402
Accrued research and development expenses		4,169		6,062
Accrued payroll and related expenses		4,849		6,094
Accrued professional fees		1,443		700
Accrued other		1,116		1,171
	$	19,191	$	22,429
Other long-term liabilities:
Uncertain tax positions	$	87	$	558
Asset retirement obligation		354		—
	$	441	$	558